![](/img/cover-not-exists.png)
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
Macerelli, M., Caramella, C., Faivre, L., Besse, B., Planchard, D., Polo, V., Ngo Camus, M., Celebic, A., Koubi-Pick, V., Lacroix, L., Pignon, J.P., Soria, J.C.Volume:
83
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2013.12.013
Date:
March, 2014
File:
PDF, 924 KB
english, 2014